Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Astrazeneca, Bristol Myers Squibb, Curium, Cybin, Daiichi, Eli Lilly, Innovent, Jiangsu Recbio, Kiora, Kyowa Kirin, Merck, Noema, Prestige, Relay, Sinovac, Valneva.